Lobular capillary hemangioma (LCH) is a benign proliferation of capillary blood vessels adopting a lobular configuration. A laryngeal origin of LCH is exceedingly rare. Here, we describe a case of an 11-year-old boy presenting with a subglottic lesion, leading to a subglottic stenosis. Histopathologic findings of the lesion implicated an LCH, which was removed successfully by a coblator. This is the first report of a subglottic LCH. Physicians should be aware of this unique lesion and laryngeal LCH should be considered in diagnosing the cause of a subglottic stenosis. Additionally, coblation should be an effective treatment for laryngeal LCH.
INTRODUCTION
Lobular capillary hemangioma (LCH), also known as pyogenic granuloma, is a benign proliferation of capillary blood vessels adopting a lobular configuration [1] . The term 'pyogenic granuloma' is a misnomer as the lesion does not contain purulent material and is not a granuloma. LCH is a smooth or lobulated red lesion on a sessile or pedunculated base that varies in size from a few millimeters and rarely exceeds 2.5 cm [2, 3] . The usual sites for this tumor are the skin and the nasopharyngeal and oral mucosal surfaces [4] . LCH in the gastrointestinal tract has also been reported [5] . LCH lesions are very rare in the airway, with only a few cases reported to date [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and subglottic LCH is unique. Here, we present the case of an 11-year-old boy who presented with a subglottic LCH, posing both a diagnostic and therapeutic challenge.
CASE REPORT
An 11-year-old Vietnamese boy presented to the Department of Otolaryngology, Children Hospital I, Ho Chi Minh City, Vietnam, with a complaint of dyspnea and dry coughing. He had been suffering from increasing dyspnea, coughing, and occasional wheezing for two weeks but had not been suffering from hoarseness or fever. He had no history of previous intubation, airway surgery, trauma, or tuberculosis.
Clinical examination of lung and heart revealed no abnormalities. Consequently, a neck and chest computed tomography (CT) with intravenous contrast was performed, which did not reveal any parenchymal lung disease. However, we observed a lesion on the left and posterior wall of the larynx, which probably caused a subglottic stenosis leading to dyspnea, wheezing, and coughing in this patient ( Figure 1) .
We further performed a laryngeal endoscopy and observed a pink soft and hyperemic lesion with smooth surface located just under the surface of the left vocal cord. Consistent with the CT scan findings, the lesion was located on the left wall of the subglottic site, leading to a grade III subglottic stenosis with a 75% obstruction (Figure 2 To follow up, a second laryngeal endoscopy was done. Surprisingly, the lesion grew into a firm red tumor on the left wall of the subglottic site, resulting in a grade III subglottic stenosis with a 95% obstruction (Figure 3) .
Aspiration of the lesion revealed no blood, and a biopsy for pathologic analysis was performed using a micro forceps. Histopathological findings of the lesion biopsy revealed a pyogenic granuloma (Figure 4 ) with a lobular pattern of vascular proliferation with inflammation and edema resembling granulation tissue covered by squamous epithelium. There was no pathological evidence of dysplasia or malignancy.
Consequently, the patient underwent an endoscopy for a complete excision of the tumor using a coblator needle-tip wand (in the coagulation mode) (Coblator II, model RE 8000E, from Arthrocare, Costa Rica 680 Vaqueros Ave, Sunnyvale CA 94085). No complications occurred during or after the procedure. The tumor specimen was sent for pathologic analysis. Histopathological findings of the specimen revealed a pyogenic granuloma. At follow-up 2 months later, a third endoscopy was performed and did not reveal any recurrent laryngeal lesion ( Figure 5 ). The patient did not suffer from dyspnea after decannulation.
DISCUSSION
LCH is also called pyogenic granuloma (PG) although it is neither induced by bacterial infection nor a true granuloma [24] . The causes of this disease remain unclear, and may include trauma, drug side effects, hormonal shifts, viral oncogenes, production of angiogenic factors, cytogenetic clonal deletion abnormalities, low-grade local irritation, and traumatic injury [14, 15, 20, [24] [25] [26] . In children, 76.9% of LCH lesions appear on the head and neck, and 76.7% of those have no history of trauma or predisposing factors. Most of the manifestations are single lesions [27, 28] .
LCH lesions are very rare in the airway, with only 18 cases reported in the trachea and the main bronchus, and 4 cases reported in neonatal vocal cords [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Table 1 summarizes all reported LCH cases, including the current one. However, to the best of our knowledge, LCH has not been described in the subglottic area previously.
Based on the clinical symptoms as well as the chest and neck CT and laryngeal endoscopy findings, a diagnosis of [29, 30] . LCH is distinguished from hemangioma clinically and histologically based on its lobular growth pattern, fibromyxoid background, overlying ulceration, and
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acute inflammation [31] . LCH is also distinguished from other neoplasms based on its histopathological findings. Consequently, biopsy for histopathology could play a key role in diagnosis of a laryngeal lesion, and LCH should be considered when diagnosing the cause of a subglottic stenosis.
Many effective treatment modalities have been reported for LCH of the airway, including endoscopic excision, electrocautery, embolization, brachytherapy, argon plasma coagulation, and cryotherapy [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . To date, there have been no comparisons among the various treatment methods for LCH located in the airway. These methods generally achieve good therapeutic effects, but long-term observation is still needed. In the present case, the laryngeal LCH lesion did not respond to intravenous propanolon, but it was successfully removed by an endoscopic coblator, which could be an effective treatment for this type of LCH. Recurrence of skin and mucosal LCH after local therapy is well-known. A recurrence rate of 16% has been reported for oral LCH; the causes were incomplete excision, failure to eradicate the etiological factors, or reinjury of the area [12] . Nevertheless, neither recurrence nor malignant degeneration has been reported with LCH of the airways [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . We recommend close follow up for patients who have a history of laryngeal LCH with endoscopy as necessary.
CONCLUSION
To the best of our knowledge, this is the first report of unique presentation and management of a subglottic LCH. Physicians should be aware of this unique lesion and consider laryngeal LCH as a differential diagnosis of subglottic stenosis, where biopsy for histopathology could play a key role in diagnosis. Moreover, coblation was effective in treating this laryngeal LCH. Finally, further studies are necessary to understand the etiology of laryngeal LCH and ensure effective treatment for these lesions.
